GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Pre-Tax Income

Cangene (FRA:YGE) Pre-Tax Income : €-1.80 Mil (TTM As of Oct. 2013)


View and export this data going back to . Start your Free Trial

What is Cangene Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Cangene's pretax income for the three months ended in Oct. 2013 was €-3.58 Mil. Its pretax income for the trailing twelve months (TTM) ended in Oct. 2013 was €-1.80 Mil. Cangene's pretax margin was -19.85%.


Cangene Pre-Tax Income Historical Data

The historical data trend for Cangene's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Pre-Tax Income Chart

Cangene Annual Data
Trend Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.93 13.90 -0.51 -26.69 6.61

Cangene Quarterly Data
Jan09 Apr09 Jul09 Oct09 Jan10 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.50 -3.01 5.65 -0.86 -3.58

Competitive Comparison of Cangene's Pre-Tax Income

For the Biotechnology subindustry, Cangene's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cangene's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cangene's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Cangene's Pre-Tax Income falls into.



Cangene Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Cangene's Pretax Income for the fiscal year that ended in Jul. 2013 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=8.65+-2.106+0+0.064+-8.8817841970013E-16
=6.61

Cangene's Pretax Income for the quarter that ended in Oct. 2013 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-2.992+-0.603+0+0.014+0
=-3.58

Pre-Tax Income for the trailing twelve months (TTM) ended in Oct. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cangene  (FRA:YGE) Pre-Tax Income Explanation

Cangene's Pretax Margin for the quarter that ended in Oct. 2013 is calculated as

Pretax Margin=Pretax Income/Revenue
=-3.581/18.043
=-19.85%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cangene Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Cangene's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Cangene (FRA:YGE) Business Description

Traded in Other Exchanges
N/A
Address
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines